Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Catalyst Pharm Inc (CPRX)

Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,816,189
  • Shares Outstanding, K 118,011
  • Annual Sales, $ 398,200 K
  • Annual Income, $ 71,410 K
  • 60-Month Beta 0.89
  • Price/Sales 4.51
  • Price/Cash Flow 7.40
  • Price/Book 4.61
Trade CPRX with:

Options Overview Details

View History
  • Implied Volatility 40.10% ( -4.28%)
  • Historical Volatility 37.09%
  • IV Percentile 23%
  • IV Rank 28.62%
  • IV High 74.43% on 10/18/23
  • IV Low 26.33% on 12/15/23
  • Put/Call Vol Ratio 0.08
  • Today's Volume 27
  • Volume Avg (30-Day) 221
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 7,291
  • Open Int (30-Day) 6,282

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.31
  • Number of Estimates 4
  • High Estimate 0.44
  • Low Estimate 0.23
  • Prior Year 0.26
  • Growth Rate Est. (year over year) +19.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.97 +4.31%
on 04/05/24
17.43 -10.41%
on 03/21/24
-0.45 (-2.83%)
since 03/15/24
3-Month
13.12 +19.05%
on 02/08/24
17.50 -10.75%
on 03/01/24
+1.26 (+8.74%)
since 01/16/24
52-Week
11.09 +40.80%
on 06/01/23
18.22 -14.30%
on 04/18/23
-2.08 (-11.73%)
since 04/14/23

Most Recent Stories

More News
3 Biopharma Stocks You Don't Want to Miss in the New Bull Market

All three have exciting programs on the way.

VRTX : 395.91 (-0.36%)
CMPS : 8.23 (-1.08%)
CPRX : 15.56 (+1.10%)
3 Biotech Stocks You Can Buy and Hold for the Next Decade

These companies are still in the early innings of their growth potential.

CPRX : 15.56 (+1.10%)
RXRX : 7.66 (-1.67%)
CRBU : 4.03 (-0.98%)
Forget Shiba Inu: This Stock is Poised for a Potential Bull Run in 2024

With multiple drugs on the market and revenue ramping up, the sky's the limit.

CPRX : 15.56 (+1.10%)
3 Robinhood Stocks to Buy Right Now

The no-cost trading platform's customers have their clear favorites, and they're more mainstream names than you might expect them to be.

AMZN : 184.38 (+0.41%)
CPRX : 15.56 (+1.10%)
ADBE : 474.48 (+0.93%)
2 Robinhood Stocks With Market-Beating Potential

These diamonds in the rough won't stay down.

CPRX : 15.56 (+1.10%)
O : 51.11 (-1.05%)
Down 19% in 1 Day, Is Catalyst Pharmaceuticals a Smart Contrarian Buy?

When evaluating investments, it helps to keep quarterly performance in context.

CPRX : 15.56 (+1.10%)
Catalyst's (CPRX) Q1 Earnings Lag, Sales Boost Revenues

Catalyst (CPRX) reports mixed results for the first quarter, wherein earnings miss and revenues beat estimates. Fycompa sales boost revenues. The company maintains revenue guidance. The stock surges 3%....

IMGN : 31.23 (unch)
CPRX : 15.56 (+1.10%)
AZYO : 1.4900 (+2.05%)
BTTX : 0.0112 (+13.13%)
Catalyst Pharmaceutical (CPRX) Misses Q1 Earnings Estimates

Catalyst (CPRX) delivered earnings and revenue surprises of -13.33% and 2.80%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CPRX : 15.56 (+1.10%)
GANX : 3.10 (+0.32%)
Catalyst (CPRX) to Report Q1 Earnings: What's in the Cards?

Catalyst's (CPRX) revenues in the first quarter of 2023 are expected to have been driven by Firdapse sales. Updates on generic competition and the commercial launch of Fycompa are expected.

IMGN : 31.23 (unch)
CYT : 3.02 (-2.27%)
CPRX : 15.56 (+1.10%)
ACRV : 9.34 (-2.81%)
3 Reasons Growth Investors Will Love Catalyst (CPRX)

Catalyst (CPRX) could produce exceptional returns because of its solid growth attributes.

CPRX : 15.56 (+1.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Catalyst Pharmaceuticals, Inc. is a development-stage biopharmaceutical company focused on the development and commercialization of therapies targeting rare neurological diseases and disorders, like Lambert-Eaton Myasthenic Syndrome (LEMS), epilepsy and Tourette syndrome. Catalyst in-licensed rights...

See More

Key Turning Points

3rd Resistance Point 16.23
2nd Resistance Point 16.05
1st Resistance Point 15.72
Last Price 15.56
1st Support Level 15.21
2nd Support Level 15.03
3rd Support Level 14.70

See More

52-Week High 18.22
Last Price 15.56
Fibonacci 61.8% 15.50
Fibonacci 50% 14.65
Fibonacci 38.2% 13.81
52-Week Low 11.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar